|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
ABSTRACT |
|---|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
In order to establish reference equations for prediction of the total distance walked during six minutes (6MWD) for healthy adults, we administered the standardized 6-min walk test to 117 healthy
men and 173 healthy women, aged 40 to 80 yr. Oxygen saturation (SaO2), pulse rate, and the degree
of dyspnea (Borg scale) were determined before and at the end of the walk. The median distance walked was 576 m for men and 494 m for women. The 6MWD was significantly less for men and
women who were older and heavier, and for shorter men. The resulting gender-specific regression
equations explained about 40% of the variance in the distance walked for healthy adults: for men,
6MWD = (7.57 × heightcm) 
(5.02 × age) (1.76 × weightkg) 309 m, and for women, 6MWD = (2.11 × heightcm) (2.29 × weightkg) (5.78 × age) + 667 m. These reference equations may be
used to compute the percent predicted 6MWD for individual adult patients performing the test for
the first time, when using the standardized protocol.
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The ability to walk for a distance is a quick and inexpensive measure of physical function, and an important component of quality of life, since it reflects the capacity to undertake day-to-day activities. The 6-min walk can be performed by many elderly, frail, and severely limited patients who cannot be tested with standard (and more expensive) maximal cycle ergometer or treadmill exercise tests. The distance walked in 6 min (6MWD) is reduced by several types of diseases, including obstructive lung disease, heart failure, arthritis, and neuromuscular disease (1, 2).
Previous studies using the 6-min walk were conducted in groups of patients with a disease associated with physical dysfunction, but did not include relatively healthy persons. We desired a standard measure of physical function in a longitudinal, population-based study, and included the 6-min walk as part of a comprehensive follow-up examination of the adults in the cohort. The results allowed determination of the predictors (based on height, weight, body mass index [BMI], age, and gender) of the 6MWD in the healthy subset of study participants.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Study Population
The subjects were participants in the Tucson Epidemiological Study of Airways Obstructive Disease. The study design and methods of data collection have been previously detailed (3). Briefly, the population in this study was a randomly chosen, stratified cluster of persons in Tucson, Arizona, consisting of 3,805 individuals in 1,655 households who were enrolled in 1972 and 1973, with new enrollees added by marriage and birth.
Six-Minute Walk Test
The 6-min walk test was conducted according to a standardized protocol (2). Subjects were instructed to walk from one end to the other of a 100-ft. hallway at their own pace, while attempting to cover as much ground as possible in the allotted 6 min. Technicians encouraged subjects with the standardized statements "You're doing well" or "Keep up the good work," but were asked not to use other phrases. Subjects were allowed to stop and rest during the test, but were instructed to resume walking as soon as they felt able to do so. Dyspnea, as measured with the modified Borg dyspnea scale (4), oxygen saturation (SaO2), and pulse rate were assessed at the start and end of the 6-min walk test. Subjects were also asked at the end of the walk whether they had experienced any of the following symptoms: dyspnea, chest pain, lightheadedness, or leg pain.
Cardiovascular Assessments
Prior to the 6-min walk test, we measured each subject's ankle-arm index (AAI), a sensitive subclinical measure of reduced blood flow to the legs (5), performed an electrocardiogram (ECG), recorded the subject's systolic blood pressure and self-reported experience of high blood pressure, and took a history of stroke, any heart problem, or any kind of heart or lung surgery since the time of the subject's completion of the last previous questionnaire. Current use of diuretic, antihypertensive, antiarrthymic, and anticoagulant medications was also self-reported.
Pulmonary Assessments
Spirometry was performed according to American Thoracic Society criteria (6), with reference values previously obtained from healthy members of our cohort (7). Subjects were classified as being never-smokers, ex-smokers, or current smokers on the basis of their self- administered questionnaire responses. Other pulmonary data collected included breathing medications, a history of lung cancer, and any serious respiratory illness, lung surgery, or limited activity related to lung disease. The subject's standing height in stocking feet was measured to the nearest centimeter, using a stadiometer, and the subject's weight was measured with a balance beam scale that was recalibrated every month.
Statistical Methods
We decided a priori to define the healthy group by excluding subjects with disease-related factors that were significantly negatively associated with 6MWD in the entire cohort. If the factor was a continuous variable, participants who fell beyond the 95th percentile toward abnormality were to be excluded from the healthy group. Therefore, the first step in our procedure was to build a linear regression model to determine the correlates of 6MWD. For the remaining healthy subset of participants, we chose the anthropomorphic factors that were significantly independently associated with 6MWD to enter into a model predicting 6MWD. The lower limit of the normal range was defined as the 5th percentile.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Two hundred and five males and 253 females completed the 6-min walk. The initial regression model (stepwise) determined the factors independently associated with a reduced 6MWD. Table 1 lists the exclusionary factors resulting from this model and the number of participants excluded for each factor. Exclusionary factors included age > 80 yr, BMI > 35 (indicating obesity), AAI < 0.90 (indicating peripheral vascular disease), a history of stroke, use of diuretics (suggesting hypertension or congestive heart failure), an FEV1 less than 70% predicted (suggesting lung disease), and current smoking. The only anthropomorphic variables that were significant in the model were age and weight, both of which had negative coefficients. Height was significantly correlated with 6MWD in men only. Figures 1 and 2 are scattergrams showing the bivariate association of age with 6MWD in men and women, including the fitted regression lines. Either weight or BMI were significant when entered into the models, and resulted in nearly equivalent values for R2.
|
|
|
After the exclusionary factors were applied, 117 men and 173 women remained in the healthy subset. Table 2 gives their characteristics. Table 3 gives the gender-specific equations for predicting 6MWD. These models explained 42% and 38% of the variation in 6MWD for men and women, respectively (R2 values). After the predicted 6WMD value from Table 3 for an individual patient is computed, the lower limit of the normal range (LLN) for that patient may be obtained by subtracting 153 m from the 6MWD value for men or by subtracting 139 m for women.
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The 12-min walking test was introduced in 1968 as a guide to physical fitness (8), and was later applied to patients with chronic obstructive pulmonary disease (COPD) (9). It was then found that decreasing the time of the walk to 6 min did not significantly reduce the utility of the test (2). The 6-min walk test has been validated by high correlation with workloads, heart rate, and SaO2, the dyspnea responses when compared with standard bicycle ergometry and treadmill exercise tests (10). There is a learning effect when the test is performed on two successive days, with a mean 15% improvement in distance walked (13), but this effect is not important when determining cross-sectional correlations, or when using the results as a baseline predictor of later events. Our results apply to the first (initial) 6-min walk performed by a patient.
In the gender-specific models, we found that the anthropometric factors of age, weight, and height (for men) were independently associated with the distance walked. The gradual reduction of skeletal muscle mass and strength that generally occurs with aging (14), and the increased prevalence of debilitating diseases, which we did not objectively measure, are probably responsible for the shorter distance walked in our more elderly study participants. A taller height is associated with a longer stride, which makes walking more efficient, probably resulting in a longer distance walked by taller men.
Obesity increases the workload for a given amount of exercise, probably resulting in the shorter distanced walked by women with a higher body weight or BMI. A small study of elderly men with COPD found that correcting for body weight improved the correlation of 6MWD with maximal oxygen consumption (12). Our results suggest that when 6MWDs are reported in future studies, they should be corrected for age, height, weight, and gender.
About 60% of the variance in 6MWD remains unexplained by our models. Future population-based studies of relatively healthy persons that include the 6-min walk test may be able to provide models that explain more of the variance and thereby narrow the normal range (and increase the lower limit of the normal range provided by our reference equations). For instance, knowledge of exercise habits and cardiopulmonary conditioning, and of the presence of musculoskeletal problems (such as arthritis), might improve future models.
The 6MWD was an excellent independent predictor of morbidity and mortality after 1 yr in 898 patients with heart failure (15). The mean distance walked by these patients was 374 m (SD = 117 m). It remains to be seen whether or not the 6MWD will be a strong independent predictor of morbidity and mortality in population samples or in patients with COPD.
Caution should be exercised when applying our regression equations to patients who have characteristics that fall outside of our cohort, including non-Causians and those younger than 40 yr or older than 80 yr. Larger values may be expected from persons who have previously performed 6-min walk tests and those to whom nonstandardized encouragement is given.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Paul Enright, M.D., UAZ/UMC Room 2342, 1501 N. Campbell Ave., Tucson, AZ 85724. E-mail: lungguy{at}aol.com
(Received in original form October 27, 1997 and in revised form May 20, 1998).
Acknowledgments: Supported by Specialized Centers of Research Grant HL14136 from the National Heart, Lung and Blood Institute.
| |
References |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1. Guyatt, G. H., M. J. Sullivan, P. J. Thompson, E. L. Fallen, S. O. Pugsley, D. W. Taylor, and L. B. Berman. 1985. The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 132: 919-923 [Abstract].
2. Butland, R. J. A., J. Pang, E. R. Gross, A. A. Woodcock, and D. M. Geddes. 1982. Two, six, and 12 minute walking tests in respiratory disease. B.M.J. 284: 1607-1608 .
3.
DiPede, C.,
G. Viegi,
J. J. Quackenboss,
P. Boyer-Pfersdorf, and
M. D. Lebowitz.
1991.
Respiratory symptoms and risk factors in an Arizona
population samples of Anglo- and Mexican-American whites.
Chest
99:
916-922
4. Wilson, R. C., and P. W. Jones. 1989. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnea during exercise. Clin. Sci. 76: 277-282 [Medline].
5. Hiatt, W. R., J. A. Marshall, J. Baxter, R. Sandoval, W. Hilderbrant, L. R. Kahn, and R. F. Hamman. 1990. Diagnostic methods for peripheral arterial disease in the San Luis Valley diabetes study. J. Clin. Epidemiol. 43: 597-606 [Medline].
6. American Thoracic Society. 1987. Standardization of spirometry: 1987 update. Am. Rev. Respir. Dis. 136: 1285-1298 [Medline].
7. Knudson, R. J., M. D. Lebowitz, C. J. Holberg, and B. Burrows. 1983. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 127: 725-734 [Medline].
8.
Cooper, K. H..
1968.
A means of assessing maximal oxygen intake.
J.A.M.A.
203:
201-204
9. McGavin, C. R., M. Artvinli, H. Naoe, and G. J. R. McHardy. 1978. Dyspnea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. B.M.J. 2: 241-243 .
10. Langenfeld, H., B. Schneider, W. Grimm, M. Beer, M. Knoche, G. Riegger, and K. Kochsiek. 1990. The six minute walk test: an adequate exercise test for pacemaker patients? PACE 13: 1761-1765 .
11.
Spence, D. P. S.,
J. G. Hay,
J. Carter,
M. G. Pearson, and
P. M. A. Calverley.
1993.
Oxygen desaturation and breathlessness during corridor
walking in COPD: effect of oxitropium bromide.
Thorax
48:
1145-1150
12.
Bernstein, M. L.,
J. A. Despars,
N. P. Singh,
K. Avalos,
D. W. Stansbury, and
R. W. Light.
1994.
Reanalysis of the 12 minute walk in patients
with COPD.
Chest
105:
163-167
13.
Leach, R. M.,
A. C. Davidson,
S. Chinn,
C. H. C. Twort,
I. R. Cameron, and
N. T. Bateman.
1992.
Portable liquid oxygen and exercise ability
in severe respiratory disability.
Thorax
47:
781-789
14. Tolep, K., and S. G. Kelsen. 1993. Effect of aging on respiratory skeletal muscles. Clin. Chest Med. 3: 363-378 .
15.
Bittner, V.,
D. H. Weiner,
S. Yusuf,
W. J. Rogers,
K. M. McIntyre,
S. I. Bangdiwala,
M. W. Kronenberg,
J. B. Kostis,
R. M. Kohn,
M. Guillotte,
B. Greenberg,
P. A. Woods, and
M. G. Bourassa.
1993.
Prediction of mortality and morbidity with a six minute walk test in patients
with left ventricular dysfunction.
J.A.M.A.
270:
1702-1707
This article has been cited by other articles:
 |
|
 |
|
  Y. SCHOINDRE, C. MEUNE, A. T. DINH-XUAN, J. AVOUAC, A. KAHAN, and Y. ALLANORE Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis J Rheumatol, July 1, 2009; 36(7): 1481 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Salzman The 6-Min Walk Test: Clinical and Research Role, Technique, Coding, and Reimbursement Chest, May 1, 2009; 135(5): 1345 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tang, K. M. Sibley, S. G. Thomas, M. T. Bayley, D. Richardson, W. E. McIlroy, and D. Brooks Effects of an Aerobic Exercise Program on Aerobic Capacity, Spatiotemporal Gait Parameters, and Functional Capacity in Subacute Stroke Neurorehabil Neural Repair, May 1, 2009; 23(4): 398 - 406. [Abstract] [PDF]
|
|
|
|
 |
|
 A M Pan, I G Stiell, C M Clement, J Acheson, and S D Aaron Feasibility of a structured 3-minute walk test as a clinical decision tool for patients presenting to the emergency department with acute dyspnoea Emerg. Med. J., April 1, 2009; 26(4): 278 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Clarke, J. E. Wraith, M. Beck, E. H. Kolodny, G. M. Pastores, J. Muenzer, D. M. Rapoport, K. I. Berger, M. Sidman, E. D. Kakkis, et al. Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I Pediatrics, January 1, 2009; 123(1): 229 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kluding and B. Gajewski Lower-Extremity Strength Differences Predict Activity Limitations in People With Chronic Stroke Physical Therapy, January 1, 2009; 89(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ugalde, S. Miro, S. Provencher, M. Quevillon, L. Chau, D. R. Deslauriers, Y. Lacasse, S. Ferland, S. Simard, and J. Deslauriers Ipsilateral Diaphragmatic Motion and Lung Function in Long-Term Pneumonectomy Patients Ann. Thorac. Surg., December 1, 2008; 86(6): 1745 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Di Meo, C. Pedone, S. Lubich, C. Pizzoli, M. Traballesi, and R. A. Incalzi Age does not hamper the response to pulmonary rehabilitation of COPD patients Age Ageing, September 1, 2008; 37(5): 530 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bourbonnais and L. Samavati Clinical predictors of pulmonary hypertension in sarcoidosis Eur. Respir. J., August 1, 2008; 32(2): 296 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. McGovern, M. P. Wasserstein, R. Giugliani, B. Bembi, M. T. Vanier, E. Mengel, S. E. Brodie, D. Mendelson, G. Skloot, R. J. Desnick, et al. A Prospective, Cross-sectional Survey Study of the Natural History of Niemann-Pick Disease Type B Pediatrics, August 1, 2008; 122(2): e341 - e349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais, O. Sitbon, D. Montani, R. Souza, G. Simonneau, F. Soubrier, et al. Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Lammers, A A Hislop, Y Flynn, and S G Haworth The 6-minute walk test: normal values for children of 4-11 years of age Arch. Dis. Child., June 1, 2008; 93(6): 464 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D Goldman, R. A. Marrie, and J. A Cohen Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls Multiple Sclerosis, April 1, 2008; 14(3): 383 - 390. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Catapano, C. Pedone, E. Nunziata, A. Zizzo, A. Passantino, and R. A. Incalzi Nutrient intake and serum cytokine pattern in elderly people with heart failure Eur J Heart Fail, April 1, 2008; 10(4): 428 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lord, K. M McPherson, H. K McNaughton, L. Rochester, and M. Weatherall How feasible is the attainment of community ambulation after stroke? A pilot randomized controlled trial to evaluate community-based physiotherapy in subacute stroke Clinical Rehabilitation, March 1, 2008; 22(3): 215 - 225. [Abstract] [PDF]
|
|
|
|
|
|
C. G. Cote, C. Casanova, J. M. Marin, M. V. Lopez, V. Pinto-Plata, M. M. de Oca, L. J. Dordelly, H. Nekach, and B. R. Celli Validation and comparison of reference equations for the 6-min walk distance test Eur. Respir. J., March 1, 2008; 31(3): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barreiro, A. Nowinski, J. Gea, and P. Sliwinski Oxidative stress in the external intercostal muscles of patients with obstructive sleep apnoea Thorax, December 1, 2007; 62(12): 1095 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fiorina, E. Vizzardi, R. Lorusso, M. Maggio, G. De Cicco, S. Nodari, P. Faggiano, and L. Dei Cas The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 724 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Li, J. Yin, J. T. Au, H. K. So, T. Tsang, E. Wong, T. F. Fok, and P. C. Ng Standard Reference for the Six-Minute-Walk Test in Healthy Children Aged 7 to 16 Years Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 174 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.K. Mutluay, R. Demir, S. Ozyilmaz, A.T. Caglar, A. Altintas, and H.N. Gurses Breathing-enhanced upper extremity exercises for patients with multiple sclerosis Clinical Rehabilitation, July 1, 2007; 21(7): 595 - 602. [Abstract] [PDF]
|
|
|
|
|
|
R. P. Baughman, B. K. Sparkman, and E. E. Lower Six-Minute Walk Test and Health Status Assessment in Sarcoidosis Chest, July 1, 2007; 132(1): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. A. van Hedel, V. Dietz, and A. Curt Assessment of Walking Speed and Distance in Subjects With an Incomplete Spinal Cord Injury Neurorehabil Neural Repair, July 1, 2007; 21(4): 295 - 301. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Tansey, M. Louie, M. Loeb, W. L. Gold, M. P. Muller, J. de Jager, J. I. Cameron, G. Tomlinson, T. Mazzulli, S. L. Walmsley, et al. One-Year Outcomes and Health Care Utilization in Survivors of Severe Acute Respiratory Syndrome Arch Intern Med, June 25, 2007; 167(12): 1312 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casanova, C. G. Cote, J. M. Marin, J. P. de Torres, A. Aguirre-Jaime, R. Mendez, L. Dordelly, and B. R. Celli The 6-min walking distance: long-term follow up in patients with COPD Eur. Respir. J., March 1, 2007; 29(3): 535 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Reesink, M. N. van der Plas, N. E. Verhey, R. P. van Steenwijk, J. J. Kloek, and P. Bresser Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 510 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Minai, C. M. Pandya, J. A. Golish, J. F. Avecillas, K. McCarthy, S. Marlow, and A. C. Arroliga Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension Chest, January 1, 2007; 131(1): 109 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-I. Raffaele, C. Andrea, P. Claudio, T. Luigi, A. Domenico, S. Aldo, I. Orsola, and R. Franco Drawing Impairment Predicts Mortality in Severe COPD Chest, December 1, 2006; 130(6): 1687 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schenkman, J. E Deutsch, and K. M Gill-Body An Integrated Framework for Decision Making in Neurologic Physical Therapist Practice Physical Therapy, December 1, 2006; 86(12): 1681 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rich The current treatment of pulmonary arterial hypertension: time to redefine success. Chest, October 1, 2006; 130(4): 1198 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lederer, S. M. Arcasoy, J. S. Wilt, F. D'Ovidio, J. R. Sonett, and S. M. Kawut Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 659 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Cheung, C. M. Tansey, G. Tomlinson, N. Diaz-Granados, A. Matte, A. Barr, S. Mehta, C. D. Mazer, C. B. Guest, T. E. Stewart, et al. Two-Year Outcomes, Health Care Use, and Costs of Survivors of Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. d. S. Alves, R. Stirbulov, and O. Avanzi Impact of a physical rehabilitation program on the respiratory function of adolescents with idiopathic scoliosis. Chest, August 1, 2006; 130(2): 500 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Galie, M. Beghetti, M. A. Gatzoulis, J. Granton, R. M.F. Berger, A. Lauer, E. Chiossi, M. Landzberg, and for the Bosentan Randomized Trial of Endothelin An Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Circulation, July 4, 2006; 114(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vivodtzev, J.-L. Pepin, G. Vottero, V. Mayer, B. Porsin, P. Levy, and B. Wuyam Improvement in Quadriceps Strength and Dyspnea in Daily Tasks After 1 Month of Electrical Stimulation in Severely Deconditioned and Malnourished COPD Chest, June 1, 2006; 129(6): 1540 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, A. Yaici, E. Weitzenblum, J.-F. Cordier, F. Chabot, et al. Pulmonary Arterial Hypertension in France: Results from a National Registry Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1023 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. H. Koppers, P. J. E. Vos, C. R. L. Boot, and H. Th. M. Folgering Exercise Performance Improves in Patients With COPD due to Respiratory Muscle Endurance Training. Chest, April 1, 2006; 129(4): 886 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garrod, J. Marshall, E. Barley, and P. W. Jones Predictors of success and failure in pulmonary rehabilitation Eur. Respir. J., April 1, 2006; 27(4): 788 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Z. Dourado, L. C. d. O. Antunes, S. E. Tanni, S. A. R. de Paiva, C. R. Padovani, and I. Godoy Relationship of Upper-Limb and Thoracic Muscle Strength to 6-min Walk Distance in COPD Patients Chest, March 1, 2006; 129(3): 551 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ingle, K. Goode, A.S.R. Rigby, J.G.F. Cleland, and A.L. Clark Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction Eur J Heart Fail, March 1, 2006; 8(2): 198 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Provencher, D. Chemla, P. Herve, O. Sitbon, M. Humbert, and G. Simonneau Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension Eur. Respir. J., January 1, 2006; 27(1): 114 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Caplan-Shaw, S. M. Arcasoy, E. Shane, D. J. Lederer, J. S. Wilt, M. K. O'Shea, V. Addesso, J. R. Sonett, and S. M. Kawut Osteoporosis in Diffuse Parenchymal Lung Disease Chest, January 1, 2006; 129(1): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Provencher, X. Jais, A. Yaici, O. Sitbon, M. Humbert, and G. Simonneau Clinical Challenges in Pulmonary Hypertension: Roger S. Mitchell Lecture Chest, December 1, 2005; 128(6_suppl): 622S - 628S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Provencher, X. Jais, A. Yaici, O. Sitbon, M. Humbert, and G. Simonneau Clinical Challenges in Pulmonary Hypertension: Roger S. Mitchell Lecture Chest, December 1, 2005; 128(6_suppl): 622S - 628S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Hoeper, I. Markevych, E. Spiekerkoetter, T. Welte, and J. Niedermeyer Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Eur. Respir. J., November 1, 2005; 26(5): 858 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Gross Chronic Obstructive Pulmonary Disease Outcome Measurements: What's Important? What's Useful? Proceedings of the ATS, November 1, 2005; 2(4): 267 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Delclaux, F. Zerah-Lancner, D. Bachir, A. Habibi, J.-L. Monin, B. Godeau, and F. Galacteros Factors Associated With Dyspnea in Adult Patients With Sickle Cell Disease Chest, November 1, 2005; 128(5): 3336 - 3344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Garcia-Talavera Randomised trial of ambulatory oxygen in oxygen-dependent COPD Eur. Respir. J., October 1, 2005; 26(4): 747 - 748. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Hui, K. T. Wong, F. W. Ko, L. S. Tam, D. P. Chan, J. Woo, and J. J.Y. Sung The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors Chest, October 1, 2005; 128(4): 2247 - 2261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ingle, R. J. Shelton, A. S. Rigby, S. Nabb, A. L. Clark, and J. G.F. Cleland The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure Eur. Heart J., September 1, 2005; 26(17): 1742 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Esposito, S. G. Thomas, L. Kingdon, and S. Ezzat Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E494 - E503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Verrill, C. Barton, W. Beasley, and W. M. Lippard The Effects of Short-term and Long-term Pulmonary Rehabilitation on Functional Capacity, Perceived Dyspnea, and Quality of Life Chest, August 1, 2005; 128(2): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. White, N. Terrin, K. B. Miller, and H. F. Ryan Impaired Respiratory and Skeletal Muscle Strength in Patients Prior to Hematopoietic Stem-Cell Transplantation Chest, July 1, 2005; 128(1): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Lord and L. Rochester Measurement of Community Ambulation After Stroke: Current Status and Future Developments Stroke, July 1, 2005; 36(7): 1457 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lacasse, R. Lecours, C. Pelletier, R. Begin, and F. Maltais Randomised trial of ambulatory oxygen in oxygen-dependent COPD Eur. Respir. J., June 1, 2005; 25(6): 1032 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D S Hui, G M Joynt, K T Wong, C D Gomersall, T S Li, G Antonio, F W Ko, M C Chan, D P Chan, M W Tong, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors Thorax, May 1, 2005; 60(5): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Laghi, A. Antonescu-Turcu, E. Collins, J. Segal, D. E. Tobin, A. Jubran, and M. J. Tobin Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 728 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Christie, J. S. Sager, S. E. Kimmel, V. N. Ahya, C. Gaughan, N. P. Blumenthal, and R. M. Kotloff Impact of Primary Graft Failure on Outcomes Following Lung Transplantation Chest, January 1, 2005; 127(1): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Opasich, S. De Feo, G. D. Pinna, G. Furgi, R. Pedretti, D. Scrutinio, and R. Tramarin Distance Walked in the 6-Minute Test Soon After Cardiac Surgery: Toward an Efficient Use in the Individual Patient Chest, December 1, 2004; 126(6): 1796 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Faggiano, A. D'Aloia, A. Gualeni, L. Brentana, and L. D. Cas The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature Eur J Heart Fail, October 1, 2004; 6(6): 687 - 691. [Full Text] [PDF]
|
|
|
|
|
|
E. Barreiro, J. Gea, C. Sanjuas, R. Marcos, J. Broquetas, and J. Milic-Emili Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma Eur. Respir. J., August 1, 2004; 24(2): 219 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Patt, L. R. Yanek, T. F. Moy, and D. M. Becker Sociodemographic, Behavioral, and Psychological Correlates of Current Overweight and Obesity in Older, Urban African American Women Health Educ Behav, August 1, 2004; 31(4_suppl): 57S - 68S. [Abstract] [PDF]
|
|
|
|
|
|
P. S. Pohl, S. Perera, P. W. Duncan, R. Maletsky, R. Whitman, and S. Studenski Gains in Distance Walking in a 3-Month Follow-Up Poststroke: What Changes? Neurorehabil Neural Repair, March 1, 2004; 18(1): 30 - 36. [Abstract] [PDF]
|
|
|
|
|
|
V.M. Pinto-Plata, C. Cote, H. Cabral, J. Taylor, and B.R. Celli The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Eur. Respir. J., January 1, 2004; 23(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Antonelli-Incalzi, C. Imperiale, V. Bellia, F. Catalano, N. Scichilone, R. Pistelli, F. Rengo, and the SaRA investigators Do GOLD stages of COPD severity really correspond to differences in health status? Eur. Respir. J., September 1, 2003; 22(3): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sciurba, G. J. Criner, S. M. Lee, Z. Mohsenifar, D. Shade, W. Slivka, and R. A. Wise Six-Minute Walk Distance in Chronic Obstructive Pulmonary Disease: Reproducibility and Effect of Walking Course Layout and Length Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1522 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Carter, D. B. Holiday, C. Nwasuruba, J. Stocks, C. Grothues, and B. Tiep 6-Minute Walk Work for Assessment of Functional Capacity in Patients With COPD Chest, May 1, 2003; 123(5): 1408 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Brooks, S. Solway, and W. J. Gibbons ATS statement on six-minute walk test Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1287 - 1287. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Garber and J. H. Friedman Effects of fatigue on physical activity and function in patients with Parkinson's disease Neurology, April 8, 2003; 60(7): 1119 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Herridge, A. M. Cheung, C. M. Tansey, A. Matte-Martyn, N. Diaz-Granados, F. Al-Saidi, A. B. Cooper, C. B. Guest, C. D. Mazer, S. Mehta, et al. One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome N. Engl. J. Med., February 20, 2003; 348(8): 683 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Enright, M. A. McBurnie, V. Bittner, R. P. Tracy, R. McNamara, A. Arnold, and A. B. Newman The 6-min Walk Test: A Quick Measure of Functional Status in Elderly Adults Chest, February 1, 2003; 123(2): 387 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujimoto, Y. Matsuzawa, S. Yamaguchi, T. Koizumi, and K. Kubo Benefits of Oxygen on Exercise Performance and Pulmonary Hemodynamics in Patients With COPD With Mild Hypoxemia* Chest, August 1, 2002; 122(2): 457 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Troosters, R. Gosselink, M. Decramer, T. M Steffen, T. A Hacker, and L. Mollinger Six-Minute Walk Test: A Valuable Test, When Properly Standardized Physical Therapy, August 1, 2002; 82(8): 826 - 828. [Full Text]
|
|
|
|
|
|
ATS Statement: Guidelines for the Six-Minute Walk Test Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 111 - 117. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Rafanan, J. A. Golish, D. S. Dinner, L. K. Hague, and A. C. Arroliga Nocturnal Hypoxemia Is Common in Primary Pulmonary Hypertension Chest, September 1, 2001; 120(3): 894 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Dean, C. L. Richards, and F. Malouin Walking speed over 10 metres overestimates locomotor capacity after stroke Clinical Rehabilitation, April 1, 2001; 15(4): 415 - 421. [Abstract] [PDF]
|
|
|
|
|
|
M. T. Knower, D. P. Dunagan, N. E. Adair, and R. Chin Jr Baseline Oxygen Saturation Predicts Exercise Desaturation Below Prescription Threshold in Patients With Chronic Obstructive Pulmonary Disease Arch Intern Med, March 12, 2001; 161(5): 732 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Solway, D. Brooks, Y. Lacasse, and S. Thomas A Qualitative Systematic Overview of the Measurement Properties of Functional Walk Tests Used in the Cardiorespiratory Domain Chest, January 1, 2001; 119(1): 256 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. VIZZA, R. D. YUSEN, J. P. LYNCH, F. FEDELE, G. ALEXANDER PATTERSON, and E. P. TRULOCK Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 819 - 825. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. JAY REFERENCE EQUATIONS FOR THE SIX-MINUTE WALK IN HEALTHY ADULTS Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1396 - 1396. [Full Text]
|
|
|
|
|
|
S. MIYAMOTO, N. NAGAYA, T. SATOH, S. KYOTANI, F. SAKAMAKI, M. FUJITA, N. NAKANISHI, and K. MIYATAKE Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension . Comparison with Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 487 - 492. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Chang, J. R. Curtis, D. L. Patrick, and G. Raghu Assessment of Health-Related Quality of Life in Patients With Interstitial Lung Disease Chest, November 1, 1999; 116(5): 1175 - 1182. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |